Skip to main content

Table 1 Clinical manifestations of patients with intestinal BS and mucocutaneous BS

From: Clinical characteristics and risk factors of intestinal involvement in Behçet’s syndrome patients: a cross-sectional study from a single center

Variables Intestinal BS (n, %) Mucocutaneous BS (n, %)
Clinical manifestations of disease first onset   
Fever 17 (17.53) 9 (5.84)
Oral ulcers 97 (100.00) 154 (100.00)
Genital ulcers 61 (62.89) 135 (87.66)
Erythema nodule 28 (28.87) 73 (47.40)
Pseudofolliculitis 25 (25.77) 39 (25.32)
Ocular involvement 5 (5.15) 0 (0.00)
Arthritis or Arthralgia 16 (16.49) 21 (13.64)
Vascular involvement 2 (2.06) 0 (0.00)
Gastrointestinal lesions 28 (28.87) 0 (0.00)
Hematologic involvement 2 (2.06) 0 (0.00)
Clinical manifestations during hospitalization   
Headache 1 (1.03) 0 (0.00)
Oral ulcers 47 (48.45) 98 (63.64)
Genital ulcers 16 (16.49) 34 (22.08)
Erythema nodule 14 (14.43) 41 (26.62)
Skin pustules 0 (0.00) 2 (1.30)
Arthralgia 7 (7.22) 0 (0)
Arthritis 2 (2.06) 0 (0)
Nausea/vomiting/abdominal pain 49 (50.52) 0 (0.00)
Diarrhea/hematochezia 23 (23.71) 0 (0.00)
Ocular involvement 3 (3.09) 0 (0.00)
Nervous system involvement 1 (1.03) 0 (0.00)
Major vessel involvement 2 (2.06) 0 (0.00)
Hematologic involvement 6 (6.19) 0 (0.00)
Surgical treatment of bowel resection 13 (13.40)